Similar results were obtained using OA as the metabolic substrate in Seahorse measurements to confirm that knockdown of CPT1A decreases FAO in colon cancer cells (Supplementary Fig. S2). The gene discussed is CPT1A; the disease is malignant colon neoplasm.